Clin2
NCT07263061Worth exploringRecruiting

Recovery of albumin after major liver and pancreas surgery

Hepatobiliary DiseasePancreas DiseaseBile Duct Diseases

Part of Digestive system clinical trials.

This trial tracks how quickly your albumin (a protein in your blood) returns to normal after major surgery on your liver, pancreas, or bile ducts, to see if that predicts your recovery. It may help doctors understand how you are healing.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
1,000 people
Ages
13 years to 80 years
Study type
Observational

Who can take part

  • You are having a major surgery on your liver, pancreas, or bile ducts.
  • You are over 12 years old.
  • You do not have a kidney condition called nephrotic syndrome.
  • You do not have a disease that causes protein loss from the gut.
  • You do not have inflammatory bowel disease or chronic liver disease.
  • Your surgery is planned, not an emergency.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT04556019Recruiting
Study of past and future liver and bile-pancreas surgeries

This is a research study using information from people who had certain liver, bile duct, and pancreas surgeries in the hospital’s surgical team. It aims to review surgical results and may help improve how these operations are done.

Pamplona, Navarre
NCT06026267Recruiting
Comparing two doses of albumin for cirrhosis patients with SBP

This trial tests whether a lower dose of albumin works as well as the standard dose for people with cirrhosis and a type of infection called spontaneous bacterial peritonitis (SBP). It aims to see if the low dose can protect kidney function while reducing side effects and costs.

New Delhi, National Capital Territory of Delhi
NCT06809088Not yet recruiting
Comparing two ways of giving albumin for kidney injury in cirrhosis

This trial tests whether giving albumin (a blood protein) in a personalized dose works better than a standard fixed dose for people with cirrhosis and sepsis-related acute kidney injury. The goal is to find a safer and more effective way to protect kidney function.

New Delhi, National Capital Territory of Delhi
NCT06318949Recruiting
Albumin changes as early signs of chronic liver disease

This study is looking at whether changes in a protein called albumin can help find liver disease earlier. It is for people who have some liver scarring but no serious complications.

Angers
NCT05056220Recruiting· Phase 3
Albumin treatment for advanced cirrhosis with fluid buildup

This trial tests whether a personalized long-term albumin (a blood protein medicine) can help people with advanced liver scarring who have fluid in the belly (ascites). It compares the personalized albumin approach to standard care to see if it improves outcomes over time.

Leuven
NCT07634549Recruiting· Phase 4
Plant-based albumin for low blood protein after liver surgery

This trial tests a new protein treatment made from rice to help patients recover from low blood protein levels that sometimes occur after liver surgery. The treatment may help your body heal better after the procedure.

Wuhan, Hubei

Hear when a new Pancreas Disease trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.